Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

NCT06039189 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate Plaque Psoriasis

Interventions

DRUG: Guselkumab
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC